Professor | Xiaoming Cheng | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Xiaoming Cheng

Contact Information

xiaoming.cheng@whu.edu.cn

Language ability

English, Chinese, German

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2003-2007 Bachelor in Biopharmaceuticals, Tongji Medical College, Huazhong University of Science and Technology 2007-2009 Master in Biochemistry and Molecular Biology, Tongji Hospital, Huazhong University of Science and Technology 2009-2015 PhD, Technical University of Munich, Germany
Work Experience	2015-2021 Postdoctoral Researcher, National Institutes of Health, USA 2021-Present Distinguished Researcher, Wuhan University
Awards	2020 NIH Young Investigator Excellence 2015 NIH Visiting Scholar Fellowship 2014 European Association for the Study of the Liver Young Scientist Award

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2003-2007 Bachelor in Biopharmaceuticals, Tongji Medical College, Huazhong University of Science and Technology
2007-2009 Master in Biochemistry and Molecular Biology, Tongji Hospital, Huazhong University of Science and Technology
2009-2015 PhD, Technical University of Munich, Germany

Work Experience

Awards

Areas of Focus	Medical Virology Molecular Mechanisms of Liver Diseases
Publications	Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection, Xiaoming Cheng et al., 2020 Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection, Xiaoming Cheng et al., 2017 Key Milestones in HCV Discovery and Therapeutics, Xiaoming Cheng et al., 2020 Clinical characteristics of COVID‐19 patients with hepatitis B virus infection—a retrospective study, Xiaoming Cheng et al., 2020 PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice, Xiaoming Cheng et al., 2019 Hepatitis B virus deregulates cell cycle to promote viral replication and a premalignant phenotype, Xiaoming Cheng et al., 2018 Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions, Xiaoming Cheng et al., 2017 Interferon-γ and Tumor Necrosis Factor-α Produced by T cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis, Xiaoming Cheng et al., 2016 Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors, Xiaoming Cheng et al., 2016 Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA, Xiaoming Cheng et al., 2014

Areas of Focus

Medical Virology
Molecular Mechanisms of Liver Diseases

Publications

Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection, Xiaoming Cheng et al., 2020
Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection, Xiaoming Cheng et al., 2017
Key Milestones in HCV Discovery and Therapeutics, Xiaoming Cheng et al., 2020
Clinical characteristics of COVID‐19 patients with hepatitis B virus infection—a retrospective study, Xiaoming Cheng et al., 2020
PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice, Xiaoming Cheng et al., 2019
Hepatitis B virus deregulates cell cycle to promote viral replication and a premalignant phenotype, Xiaoming Cheng et al., 2018
Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions, Xiaoming Cheng et al., 2017
Interferon-γ and Tumor Necrosis Factor-α Produced by T cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis, Xiaoming Cheng et al., 2016
Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors, Xiaoming Cheng et al., 2016
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA, Xiaoming Cheng et al., 2014

Virology Hepatitis Hbv Hdv Liver Cancer Cirrhosis Viral Immunity Antiviral Targets Molecular Biology Liver Pathology

Pingzheng Mo - Wuhan University

Yongxi Zhang - Wuhan University

Li Ping Deng - Wuhan University

View All

Personal Information